ORLANDO, Fla., April 23, 2014 /PRNewswire/ -- Signature
Exploration and Production Corp. (OTCQB: SXLP) has changed its name
to GlowBLOX Sciences, Inc. The Company expects to be trading under
its new name and ticker symbol "GBLX" on April 28, 2014.
About GrowBlox Sciences, Inc.
Growblox has developed a proprietary indoor growing chamber
specifically designed for medical cannabis cultivation in which
cannabis can be grown hydroponically under completely controlled
conditions, ensuring the manufacture of a consistent, toxin-free,
natural and medicinal grade product. Further, the controlled
environment makes monitoring growth and measurement of actual
production simple, automatic and precise. The Company believes that
the advantages of a controlled environment over typical, haphazard
outdoor or greenhouse growing will enable the public, and the
nutriceutical and pharmaceutical industries, to embrace cannabis
for what it is and has always been—an effective treatment for
glaucoma, epilepsy, pain and many other maladies. We believe
GrowBlox Sciences will set the new standard for consistent medical
cannabis production in all legal states.
Therefore, In addition to bringing its proprietary growing
technology to market, the company intends to pursue a strategy of
entering the neutraceutical market, and ultimately the botanical
pharmaceutical market, in part by providing a pure product with
specific characteristics—through advanced plant genetics—as may be
considered effective for particular uses of cannabis.
Forward-Looking Statements
Except for historical information contained herein, the
statements in this release are forward-looking and made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are inherently
unreliable and actual results may differ materially. Examples of
forward-looking statements in this news release include statements
regarding the payment of dividends, marketing and distribution
plans, development activities and anticipated operating results.
Factors which could cause actual results to differ materially from
these forward-looking statements include such factors as the
Company's ability to accomplish its business initiatives,
significant fluctuations in marketing expenses and ability to
achieve and expand significant levels of revenues, or recognize net
income, from the sale of its products and services, as well as the
introduction of competing products, or management's ability to
attract and maintain qualified personnel necessary for the
development and commercialization of its planned products, and
other information that may be detailed from time to time in the
Company's filings with the United States Securities and Exchange
Commission. The Company undertakes no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
Contact: GlowBLOX Sciences, Inc., 844-843-2569
SOURCE GlowBLOX Sciences, Inc.